The clinical features of three babies with osteogenesis imperfecta resulting from the substitution of glycine by arginine in the pro alpha 1(I) chain of type I procollagen.
Open Access
- 1 April 1990
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 27 (4) , 228-235
- https://doi.org/10.1136/jmg.27.4.228
Abstract
The features of three babies with lethal perinatal osteogenesis imperfecta resulting from the substitution of glycine by arginine in the pro alpha 1(I) chain of type I procollagen were studied. The babies were heterozygous for this substitution at residue 391 in case 1 (0I24), 667 in case 2 (0I51), and 976 in case 3 (0I30). They were all small, term babies who died soon after birth. The ribs were broad and continuously beaded in 0I24, discontinuously beaded in 0I51, and slender with few fractures in 0I30. The overall radiographical classifications were type IIA in 0I24, IIA/IIB in 0I51, and IIB in 0I30. Histological examination confirmed that the long bones were misshapen and porotic. The calcified cartilage trabeculae were covered with an abnormally thin layer of osteoid and the bone trabeculae were thin and basophilic. There was no evidence of lamellar bone or Haversian systems. The osteoblasts remained relatively large and closely spaced. These babies shared many phenotypic features, but differences in the radiographical appearance of the ribs and long bones suggested that there was a gradient of bone modelling capacity from the slender and overmodelled bones in 0I30 to the absence of modelling in 0I24.This publication has 22 references indexed in Scilit:
- Osteogenesis imperfecta. The position of substitution for glycine by cysteine in the triple helical domain of the pro alpha 1(I) chains of type I collagen determines the clinical phenotype.Journal of Clinical Investigation, 1989
- A lethal variant of osteogenesis imperfecta has a single base mutation that substitutes cysteine for glycine 904 of the alpha 1(I) chain of type I procollagen. The asymptomatic mother has an unidentified mutation producing an overmodified and unstable type I procollagen.Journal of Clinical Investigation, 1989
- Perinatal lethal osteogenesis imperfecta in transgenic mice bearing an engineered mutant pro-α1(I) collagen geneNature, 1988
- Perinatal Lethal Osteogenesis Imperfecta: Radiologic and Pathologic Evaluation of Seven Prenatally Diagnosed CasesPediatric Pathology, 1988
- Collagen defects in lethal perinatal osteogenesis imperfectaBiochemical Journal, 1986
- Lethal osteogenesis imperfecta resulting from a single nucleotide change in one human pro alpha 1(I) collagen allele.Proceedings of the National Academy of Sciences, 1986
- Osteogenesis imperfecta type II delineation of the phenotype with reference to genetic heterogeneityAmerican Journal of Medical Genetics, 1984
- Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfectaBiochemical Journal, 1984
- Revised intrauterine growth curves for an Australian hospital populationJournal of Paediatrics and Child Health, 1983